QMN) ¶ These authors contributed equally to this work. Abstract Acute pancreatitis (AP) is acute inflammation of the pancreas, mainly caused by gallstones and alcohol, driven by changes in communication between cells. Heparin-binding proteins (HBPs) play a central role in health and diseases. Therefore, we used heparin affinity proteomics to identify extracellular HBPs in pancreas and plasma of normal mice and in a caerulein mouse model of AP. Many new extracellular HBPs (360) were discovered in the pancreas, taking the total number of HBPs known to 786. Extracellular pancreas HBPs form highly interconnected protein-protein interaction networks in both normal pancreas (NP) and AP. Thus, HBPs represent an important set of extracellular proteins with significant regulatory potential in the pancreas. HBPs in NP are associated with biological functions such as molecular transport and cellular movement that underlie pancreatic homeostasis. However, in AP HBPs are associated with additional inflammatory processes such as acute phase response signalling, complement activation and mitochondrial dysfunction, which has a central role in the development of AP. Plasma HBPs in AP included known AP biomarkers such as serum amyloid A, as well as emerging targets such as histone H2A. Other HBPs such as alpha 2-HS glycoprotein (AHSG) and histidine-rich glycoprotein (HRG) need further investigation for potential applications in the management of AP. Pancreas HBPs are extracellular and so easily accessible and are potential drug targets in AP, whereas plasma HBPs represent potential biomarkers for AP. Thus, their identification paves the way to determine which HBPs may have potential applications in the management of AP.
Introduction
The pancreas develops from endodermal cells in the foregut and has important exocrine and endocrine functions (1) . Acute pancreatitis (AP) is acute inflammation of the pancreas and is mainly caused by gallstones and alcohol (2) . It is a leading gastrointestinal cause of hospitalization and has significant quality of life implications for the patient and cost implications for health systems (3) . Although most episodes of AP are mild and self-limiting, the severe form of the disease, accompanied by a systemic inflammatory response syndrome and multi-organ failure, is associated with a high mortality. At a cellular level disruption of calcium signaling and mitochondrial dysfunction have been implicated in the pathogenesis of AP (4, 5) .
The clinical characteristics of AP suggest that an important molecular component is change in cell communication within the pancreas and, in severe AP, systemically between the pancreas and other organs. Cell communication occurs between cells through the medium of the extracellular matrix, with cell receptors responsible for generating the cellular response. The importance of extracellular proteins in mediating communication between cells in multicellular organisms is underscored by the demonstration that the increase in multicellular organism complexity is accompanied by an expansion and increase in the complexity of extracellular proteins (6) . A key non-protein component of the extracellular space is the glycosaminoglycan heparan sulfate (HS), because it binds and regulates the activity of a large number of extracellular proteins involved in cell communication ( (7) ; reviewed in (8) ; (9) ).
HS is formed of linear repeats of a disaccharide of 1,4 linked uronic acid (α-L-iduronate, IdoA, or β-D-glucuronate, GlcA) and α-D-N-acetylglucosamine (GlcNAc), with variable Osulfation of C2 on the uronic acid, of C3 and C6 on the glucosamine; the glucosamine being either N-acetylated or N-sulfated (8, 9) . These modifications are hierarchical (9, 10) , resulting in chains with a distinct domain structure (11) ; heparin-binding proteins (HBPs) bind to the sulfated domains and their flanking transition domains. HS chains are attached to proteins to form proteoglycans (HSPGs), with the core proteins serving in part to direct chains to particular extracellular locations (9) . Heparin is often used as a proxy for the sulfated domains of HS, though it is more homogenous and sulfated than these (8) .
Many individual studies have demonstrated a variety of mechanisms whereby binding to HS regulates the function of extracellular proteins, but only recently has this been analysed on a global scale (7) . The latter work demonstrated that of the extracellular proteins, the HBPs form a highly interconnected functional network through protein-protein interactions that are linked to physiological and pathological processes in more complex multicellular organisms.
Along with the numerous studies on individual proteins, the HBPs have been demonstrated to be important signalling molecules in the cellular microenvironment that influence fundamental biological processes in development, homeostasis and disease (7, 9, 12) .
We previously used mRNA expression data as a proxy for protein to test the hypothesis that HBPs, which are demonstrably functionally important at a genome-wide level (7) , are equally important in the context of a single organ, the pancreas, and its associated digestive diseases (13) . This work showed that HBPs are indeed a key subclass of extracellular proteins, whose pattern of expression differs in the healthy and diseased pancreas. However, this work has compromises, since mRNA expression does not always correlate with protein expression (14) (15) (16) . Moreover, the use of mRNA assumes that the existing set of 435 HBPs (7) is reasonably representative of those expressed in pancreas and that this organ does not express novel HBPs. From the perspective of pancreatic diseases, HBPs, because they bind to heparin and are extracellular, represent easily accessible new targets for the development of drugs.
However, from a biomarker perspective, sampling pancreas HBPs would be invasive.
We have, therefore, undertaken a proteomic analysis of HBPs in the pancreas and plasma of normal mouse and in the caerulein-induced mouse model of AP. We identified 360 extracellular HBPs in pancreas that were not previously known to bind the polysaccharide.
Analysis of the protein-protein interactions of the extracellular pancreas and plasma HBPs demonstrates that they are highly interconnected in NP and AP. Label-free quantification by mass spectrometry identified a number of HBPs, including some known biomarkers of AP, such as carboxypeptidases (CPB1 and CPB2) and pancreatic amylase (AMY2A) (17), which were overexpressed in AP as compared to NP. Isolation of plasma HBPs by heparin affinity chromatography resulted in a reduction of the high abundance protein albumin, so that it would not interfere with mass spectrometry. Of the 151 plasma HBPs isolated, some were known biomarkers of AP, such as serum amyloid A (SAA) while others were emerging novel markers and drug targets in AP such as histone H2A. These may provide a route to applications in the management of AP.
Methods

HBPs from pancreas
Pancreatic murine models -CD1 mice were used in all experiments, as they are genetically heterogeneous and more likely to represent the human population (18) . Pancreases were obtained from 6-8 week old male adult CD1 mice (weight range, 24-30 g) with normal pancreas (NP) or experimental acute pancreatitis (AP). In order to induce experimental acute pancreatitis, CD1 mice were fasted for 12 hours before each experiment, following which they were administered seven hourly intraperitoneal injections of caerulein (50 µg/kg; Sigma-Aldrich, Gillingham UK) dissolved in 0.9% (w/v) saline (Braun Medical, Aylesbury, England). Pancreatitis was confirmed in the experimental mice 24 hours after the first intraperitoneal injection. All mice (NP and AP) were euthanized by cervical dislocation.
Studies were conducted in compliance with UK Home Office regulations (PL4003320), and were approved by the Institutional ethical review Committee of the University of Liverpool.
A blood sample was collected for serum amylase determination. Serum amylase activity was tested in the Clinical Biochemistry Department in Royal Liverpool University Hospital. A sliver of pancreatic tissue from each of the pancreases was fixed in formalin for H&E staining and histological examination. The pancreases were removed, weighed, pooled together and placed in buffer H (10 mM HEPES pH 7.5, 5 mM MgCl 2 , 25 mM KCl, 0.25 M sucrose supplemented with Complete protease inhibitors cocktail, Roche Products Ltd, Welwyn Garden City, UK) at 4 °C. Complete protease inhibitor was used in all experiments as it has been shown to be particularly effective in experiments involving pancreatic tissue (19) .
Sixteen CD1 mice were used for each HBP isolation experiment. Each experiment was performed three times for NP and for AP.
Isolation of a plasma membrane enriched fraction -The isolation of the plasma membrane
from murine pancreases was performed as described (7) , with minor modifications. All the steps were performed on ice or at 4 °C. Briefly, mouse pancreases were minced and homogenised with buffer H using a 30 mL Potter-Elvehjem homogeniser (30-40 strokes).
Subcellular fractionation was performed using sequential steps of centrifugation. The homogenate was centrifuged for 20 min at 1,000 g in a Sorvall centrifuge (SS-34 rotor, DuPont UK, Stevenage, UK). The pellet was resuspended with buffer H, homogenised and centrifuged again. The two supernatants were then combined (S1) and centrifuged for 20 min at 25,000 g. This supernatant was transferred to a fresh tube and the centrifugation repeated.
The final supernatant (S2) was centrifuged for 45 min at 135,000 g in a Sorvall Ultra Pro 80 ultracentrifuge (T.865.1 rotor) to produce a microsomal pellet, which was washed with 8 mL of buffer H (W) by resuspension and centrifuged as above.
The final microsomal pellet was resuspended by homogenisation in a Dounce homogeniser (5 mL) with 4 mL of 1.55 M sucrose in buffer H and placed on a 2 mL 2 M sucrose cushion in a swing-bucket ultracentrifuge tube. It was then overlaid with 2.5 mL 1.33 M, 2 mL 1. Sample preparation for mass spectrometry -Trichloroacetic acid (TCA, 70% w/v) was added to an equal volume of the heparin-bound fraction and kept at -20°C for 1 hour, followed by centrifugation at 14,000 rpm for 10 minutes. After removing the supernatant fraction carefully with a glass pipette, the pellet was washed 5 times with 5% (w/v) TCA. The pellet was freezedried overnight, washed subsequently with 0.5 mL diethyl ether to remove the excess TCA and centrifuged at 5,000 rpm. The supernatant was removed and the diethyl ether wash was repeated two more times. The final pellet was left to dry in the fume hood. Label-free quantification was performed following the "Top3" methodology (20) by the spiking of the sample prior to analysis with the internal standard of 50 fmol yeast alcohol dehydrogenase digest (Uniprot P00330, Waters). Proteins were annotated as differentially expressed if they achieved a FDR corrected q value of 1 %. Additionally, an adjusted threshold p value of less than 0.001 following the Bonferroni correction was used to identify the HBPs as potential biomarkers (21) .
Identification of extracellular HBPs in NP and AP -Extracellular proteins were identified
using a combination of bioinformatics tools. SignalP 4.1, which predicts the presence of a secretory signal peptide, was used to identify extracellular proteins (22) with Phobius, which is a combined transmembrane topology and signal peptide prediction tool, to obtain a wider coverage for extracellular protein identification (23) . A third tool, SecretomeP 2.0, was used to produce ab initio predictions of protein secretion not based on a secretory signal peptide (24) . A fourth tool QIAGEN's Ingenuity Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity), was used to identify extracellular and plasma membrane proteins. The HBPs that were not identified using SignalP, Phobius, or SecretomeP, but which were identified using IPA were further investigated using a manual approach. In addition, candidate HBPs identified by SignalP, Phobius or SecretomeP that were classified as not being extracellular using IPA were further examined using a manual approach. Each candidate HBP was examined using UniProtKB (25) for the presence of an extracellular signature. The outputs of the various approaches were merged to obtain the complete list of HBPs in NP and AP.
Interactions and construction of networks of HBPs -Interactions between HBPs were obtained from the online database resource 'Search Tool for the Retrieval of Interacting
Genes' (STRING). STRING 10.5 is a database of known and predicted functional interactions and served as a 'one-stop' comprehensive resource for network creation and analysis (26).
The interactions in STRING are provided with a probabilistic confidence score that is an estimate of how likely an interaction describes a functional linkage between two proteins. A higher score indicating a higher confidence is attributed when more than one type of information supports a given association. Only interactions with a high confidence score (0.70 and above) were used to build HBP networks in NP and AP. The resulting networks were termed 'protein interactomes'. A network is deemed to be well connected if its average clustering coefficient is significantly higher than that of its corresponding random networks (27) .
Functional analyses of extracellular pancreas HBPs in NP and AP
Canonical pathways and bio-functions analyses -Canonical pathways are well-characterized signalling pathways that have been curated from original data. Bio-functions are molecular and cellular functions that play important roles in homeostasis in health and disease. The significance of the association between the datasets and the canonical pathway/bio-function was measured by calculating the p-value using Fisher's exact test to determine the probability of the association between the HBPs in the dataset and the canonical pathway/bio-function.
Canonical pathways and bio-function analyses are useful tools for the identification of potential biomarkers and drug targets. These were undertaken using IPA. They also help identify biological pathways that play important roles in homeostasis and complex diseases.
Plasma HBPs
This method is deposited at protocols.io (dx.doi.org/10.17504/protocols.io.wdtfa6n).
Sample collection
Blood obtained from 6-8 week old male adult CD1 mice (weight range, 24-30 g) with normal pancreas (NP) or experimental acute pancreatitis (AP), induced as described above, was collected in 0.38 % (w/v) sodium citrate (Sigma-Aldrich, Gillingham, UK) and centrifuged at 5,000 g at 4 ˚C for 15 min (28) . Supernatant plasma was extracted and frozen at -20 ˚C.
Heparin affinity chromatography
The frozen murine plasma was defrosted on ice and centrifuged at 16,100 g for 10 min, at 
Protein adsorption using StrataClean for mass spectrometry
In order to eliminate the high concentration of electrolytes (2.15 M NaCl) in the eluate, so as not to influence MS analysis, StrataClean TM beads (Agilent Technologies, UK) were used to adsorb proteins (29) . Briefly, 100 µg of the heparin-bound fraction was mixed with 30 µL StrataClean slurry, vortexed for 2 min. and centrifuged at 2,000 g for 2 min at 4 ˚C. The supernatant was removed carefully and discarded. The pellet was first washed with PBS and then further washed twice with H 2 O.
Sample preparation for mass spectrometry
In the case of plasma samples, the StrataClean TM beads were resuspended in 80 
Results
Isolation of pancreas HBPs from plasma membrane enriched fractions from normal pancreas and a murine model of acute pancreatitis
Each extracellular pancreas HBP isolation experiment was performed three times using Triton-X-100, proteins that remained bound were deemed to have a sufficiently strong interaction with the polysaccharide to be considered as HBPs. In contrast to previous work (7) , here a single elution at 2 M NaCl with 0.1 % (v/v) Triton X-100 was used to recover heparin-binding proteins. The rationale was that the concentration of NaCl required for elution from heparin does not necessarily correlate with affinity for HS (33, 34) , so fractionating the HBPs does not necessarily yield useful information.
MS analysis of the pancreas HBPs
Proteins in the 2 M NaCl eluates were precipitated with TCA to remove Triton-X-100, and then digested with trypsin. After ascertaining the optimal loading concentration, the sample order was randomised across biological (three each NP and AP) and technical repeats prior to There was little variation between the technical replicates for the samples, which can be attributed to the high quality of the sample preparation and MS analysis ( Fig. 3) . Each technical replicate produced between 1500-1900 protein hits at a peptide FDR of 1 %. To obtain a fuller coverage, the data were run through Progenesis label-free software. The merged file yielded over 1,900 hits at a peptide FDR of 1 %. Using a two-peptide stringency, these were reduced to 1,602 proteins in NP and 1,866 proteins in AP (Supplementary Tables 1 and 2).
Identification of the extracellular HBPs
The 1,602 proteins in NP and 1,866 proteins in AP were then filtered by the bioinformatics pipeline described in "Experimental Procedures" to identify those possessing extracellular (partially or wholly) amino acid sequence. Application of this pipeline required in many instances multiple iterations, because no single approach provided unequivocal evidence for an extracellular location of at least part of the protein sequence. Moreover, a greater confidence was obtained if more than one tool demonstrated extracellular localization. For example, SignalP and Phobius identify proteins with signal peptides, which may be secreted extracellularly, located on the plasma membrane or on an internal cell membrane. Thus secretomeP and IPA provided both a filter for the output of SignalP and Phobius, as well as identifying new candidate extracellular proteins. IPA in particular identified a good many proteins as extracellular that were not identified as such by these other tools. In all cases information on protein localisation and function was examined in UniprotKB. When only one tool, e.g., IPA indicated extracellular localisation, confirmation was sought either through UniprotKB and/or the literature. Filtering the proteins as described above resulted in 320 proteins in NP ( Supplementary Table 3 ) and 345 proteins in AP ( Supplementary Table 4) being identified as heparin binding and extracellular. Combining these two sets of proteins yielded 440 HBPs, of which 360 had not been identified previously as heparin binding. With such a substantial number of new HBPs, it was important to analyse their functions and relationships to gain insight into the significance of the pancreas and AP associated HBPs.
Label-free quantification
Using the "Top3" methodology, proteins were annotated as differentially expressed between NP and AP if they achieved a FDR corrected q value of 1 % ( Supplementary Tables 5 and 6 ). CPB2  89  Ngp  78  HRG  76  PRSS3  57  SERPINC1  43  ITIH2  43  PLG  42  COL6A3  41  SERPIND1  36  CTRC  36  FN1  35  AHSG  30  SERPINA1  27  COL1A2  25  PRG2  23  SERPINA3  20  F2  20  Ear3  19  CPB1 17 Table 1 . Top 20 extracellular pancreas HBPs overexpressed in AP. The upregulated HBPs were filtered depending on the maximum fold change values. An adjusted threshold p value of less than 0.001 following the Bonferroni correction was used to identify the top HBPs to be validated as potential biomarkers. Table 2 . Top 20 extracellular pancreas HBPs underexpressed in AP. The downregulated HBPs were filtered depending on the maximum fold change values. An adjusted threshold p value of less than 0.001 following the Bonferroni correction was used to identify the top HBPs to be validated as potential biomarkers.
HBP Max fold change
SLC4A7 -13 SLC4A2 -10 KCNQ1 -10 TFRC -8 CLPS -7 CLTB -7 CNNM2 -5 SLC7A1 -5 SIDT2 -4 CCKAR -3 MPP7 -3 CCDC93 -3 VAMP2 -3 ATP11C -3 SLC38A3 -3 SNTB1 -3 SLC9A3R2 -3 SLC7A2 -3 VAMP3 -3 SLC4A7 -13
Network construction and analysis of HBPs in the pancreas -The lists of HBPs in NP and AP
were used to obtain protein-protein interactions (PPI) from STRING. Only interactions with a high confidence score (0.70 and above) were used to construct extracellular heparin-binding protein interactomes in NP ( Fig. 4) and AP (Fig. 5) . The topological parameters of the HBP interactomes were obtained from STRING 10.5. The extracellular HBP interactomes of NP and AP have high clustering coefficients (NP = 0.364 and AP = 0.435), which were also significantly higher than those of their corresponding random networks. The PPI enrichment p-values for both extracellular pancreas HBP interactomes were < 1.0e-16. These findings suggest that the HBP interactomes form highly interconnected modules (27, 40) Analysis of the bio-functions associated with the HBPs in NP ( Supplementary Table 9 ) and AP ( Supplementary Table 10 ) support the conclusions reached from the analysis of canonical pathways.
Canonical Pathways -log (p-value)
Signaling Table 3 . Top 20 canonical pathways enriched to extracellular pancreas HBPs in NP using Ingenuity Pathways Analysis. The significance of the association between the datasets and the canonical pathway was measured by calculating the p-value using Fisher's exact test to determine the probability of the association between the HBPs in the dataset and the canonical pathway. Table 4 . Top 20 canonical pathways enriched to extracellular pancreas HBPs in experimental AP using Ingenuity Pathways Analysis. The significance of the association between the datasets and the canonical pathway was measured by calculating the p-value using Fisher's exact test to determine the probability of the association between the HBPs in the dataset and the canonical pathway.
Plasma HBPs
Identification of the plasma HBPs
Each plasma HBP isolation experiment was performed three times using blood obtained by cardiac puncture from control (NP) and AP mice. Acute pancreatitis was induced in animals as described previously. Histological and biochemical confirmation was consistent with the successful induction of AP (Supplementary figure 2) .
The high abundance of serum albumin can pose problems for the analysis of plasma proteins by mass spectrometry. However, this protein does not bind heparin in the presence of electrolytes. To ensure initial binding of HBPs from plasma to heparin, the sample was applied to the heparin column in the lowest electrolyte concentration that prevented serum albumin binding. Thus, the citrated murine plasma was diluted with a PBS (150 mM NaCl)
that was itself diluted with H 2 O to reduce the NaCl concentration to 75 mM. This was effective in reducing the albumin levels significantly in the eluate from the heparin column Table 11 ) and 151 plasma HBPs in AP ( Supplementary   Table 12 ).
Label-free quantification
Label-free quantification was performed following the "Top3" methodology, as previously described (Fig. 6 ). This identified 69 HBPs that were overexpressed ( Supplementary Table   13 ), which included known biomarkers of AP such as serum amyloid A (SAA) as well as emerging novel markers and drug targets in AP such as histone H2A (Table 5) , and 81 that were underexpressed (supplementary Table 14 ) in AP. Interestingly, HRG, which was overexpressed in the pancreas in AP, was underexpressed in plasma in AP. SAA1  141  Svs4  70  HP  15  LBP  6  TNNI3  4  Ngp  3  TNNT2  3  ITIH4  2  H2AFZ  2  Prg4  2   Table 5 . Top 20 Plasma HBPs overexpressed in AP. The upregulated HBPs were filtered depending on the maximum fold change values.
Plasma HBP Max fold change
Discussion
HBPs are functionally associated with the regulation of cell communication that underlies many physiological and pathological processes. AP represents a disease with unmet clinical need from the perspective of prognosis and treatment, particularly with respect to progression to severe AP, which can be life-threatening. Encouraged by the initial work using mRNA as a proxy for pancreas HBPs (13), we, therefore, determined whether there were changes in the levels of HBPs associated with AP in the murine caerulein model of the disease. One focus was on extracellular HBPs of the pancreas itself. Only extracellular HBPs were considered, because, whilst there is clear evidence for intracellular HS (42) (43) (44) , there is no means at present to distinguish in a proteomic experiment intracellular proteins that interact with intracellular HS from those that natively interact solely with another intracellular polyanion, such as phosphorylated lipids and nucleic acids. The present analysis aimed to identify disease-related HBPs, and so processes, some of which may be potential therapeutic targets.
However, potential biomarkers need to be more accessible, as sampling the pancreas is invasive, so plasma HBPs were also analysed. In this instance, because plasma is by definition cell-free, potentially intracellular proteins were also of interest. Moreover, the presence of exosome-associated proteins (supplementary Tables 3, 4, 11 & 12) is consistent with at least a subset of these vesicles binding heparin (45) (46) (47) .
A number of tools were used to identify pancreas HBPs with significant amino acid sequence in the extracellular space, including SignalP, Phobius, SecretomeP, IPA, and manual curation for the presence of an extracellular signature using Uniprot-KB and PubMed. In a previous analysis of rat liver a bioinformatics pipeline based on ontology (gene ontology and ingenuity ontology, IPA) was combined with manual curation to identify 62 HBPs, of which 12 were previously known to bind to heparin (7) . Middaugh and coworkers employing an antibody array on total cell lysate before and after depletion of HBPs by heparin agarose beads, identified 29 proteins whose signal was significantly reduced after incubation of the cell lysate with heparin beads, though only three were extracellular (48) . Our present approach identified 360 new extracellular HBPs that were not previously known to bind the polysaccharide (7) .
While plasma provides a rich and accessible repository of proteins, the large dynamic range of protein concentrations and high abundance proteins such as albumin pose a significant challenge to effective protein discovery (49, 50) . However, albumin does not bind heparin in the presence of electrolytes and to ensure initial binding of HBPs from plasma to heparin, the sample was applied to the heparin column in the lowest electrolyte concentration that prevented serum albumin binding. In addition to extracellular/secreted proteins, a number of nuclear proteins such as histone H2A, cytoplasmic proteins such as FERMT3 (fermitin family member 3) and endoplasmic reticulum proteins such as HSPA5 (heat shock protein A5) were also detected in plasma.
An important question is how representative are the HBPs identified here of the proteins in NP and AP whose function depends on, or is modified by, interaction with HS. The mass spectrometry is limited by the depth of the analysis and only accepting identifications based on at least two peptides and a maximum false discovery rate of 1 %. This in itself leads to false positives and false negatives. To reduce further the number of false positives for the purpose of biomarker identification, stringency was increased by using the Bonferroni correction (21) . There are additional factors that are likely to contribute to the false positives and false negatives. Some HBPs may escape detection, because they are part of large macromolecular assemblies that are not solubilised by Triton-X-100, associated with, for example, matrix fibrils, membrane microdomains or cytoskeleton. Moreover, not all HSbinding proteins will necessarily bind the heparin column and may instead remain bound to HS proteoglycans during affinity chromatography. Indeed, the transition and S-domains of HS have far more diverse structures than heparin (8, 9) . Thus, the present analysis will have a bias towards HBPs that bind structures present in the trisulfated disaccharide repeat of heparin, which makes up 75% of the polysaccharide and contains 2-O sulfated iduronate, N-, 6-O sulfated glucosamine. A source of false positives would be proteins that do not bind HS, but are bound to an HBP with a sufficiently slow dissociation rate constant that they would be carried though the affinity chromatography, an interaction that would be consistent with biological function. Apart from the limits imposed on the mass spectrometry analysis, the other sources of false positives and negatives are not currently quantifiable, until such time as the interaction of each HBP with the polysaccharide is measured directly.
A recurrent question is how specific or selective is a protein-HS interaction (8, 9) . This will be important in terms of understanding the mechanism whereby HS regulates the activity of a protein. HS has been shown to directly control the movement of a protein, fibroblast growth factor-2 in the pericellular matrix (51) . Thus, regardless of specificity and selectivity of the interaction of a protein with HS, this will restrict the movement of the protein in the extracellular space and so affect its function in terms of location and local concentration.
Therefore, proteins that bind heparin in PBS and that remain bound during the extensive washing of the affinity column have a relatively slow dissociation rate constant and would be expected to have at least their movement and extracellular location regulated by HS. Taking into account the caveats described above regarding false positives, the HBPs identified here are thus likely to have at least this aspect of their function regulated in this way by HS in the extracellular space of NP and AP. Any changes in the structure of HS that might accompany AP may, therefore, alter the movement of the HBP and so its contribution to cell physiology.
Thus, the heparin interactome is now substantially larger than previously described (7) .
Importantly, the protein-protein interaction network of the HBPs retains the key properties of the earlier, smaller interactome and hence its functional relevance to the regulation of cell communication by extracellular proteins (7) . Thus, the HBP interactome is highly interconnected and HBPs form numerous regulatory modules in the extracellular space.
Importantly, this is true for the subset of HBPs expressed by a single organ, the pancreas and one of its associated diseases, AP. Thus, it may be that for most if not all organs, HBPs represent a highly interconnected set of extracellular proteins, which have significant regulatory potential.
This work has identified a range of changes that provide deeper insight into known mechanisms in AP. A number of biomarkers that have been previously investigated in AP, such as carboxypeptidase B and pancreatic amylase, are amongst the HBPs that exhibited a significant increase in the extracellular pancreas AP dataset (Table 1 and Supplementary   Table 5 ). Others such as SAA1 are significantly overexpressed in plasma in AP (52) . Some of the most highly expressed pancreas HBPs such as NGP and HRG are representative of the underlying role of innate immunity in early AP. NGP overexpression indicates the early presence of neutrophils in AP (53), which have been shown to play an important role in AP (37) . Neutrophil extracellular traps (NETs) are composed of extracellular DNA, neutrophilderived granule proteins, and histones and are produced in AP as well as play a critical role in its development (54) . HRG is an important mediator of macrophage clearance of apoptotic cells (38) and plays important roles in the adhesion and spread of activated T-cells (39) . In contrast to its elevated levels in the pancreas, HRG is underexpressed in plasma in AP.
Histone H2A levels were significantly increased in plasma in AP. The quantitative assessment of histones in plasma has been demonstrated to accurately predict persistent organ failure and mortality in AP (55) . Thus, the HBPs exhibiting the greatest fold change (Table 1) differences between the biological conditions. A higher degree of variability is observed in the AP samples presumably reflecting the systemic effects of AP. 
